AIM

$0.52+0.00 (+0.08%)

Pre-Market$0.52-0.00 (-0.35%)· Last close May 5

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO